Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treatment.com Ai Inc (OP: TREIF )

0.5000 -0.0448 (-8.22%)
Streaming Delayed Price Updated: 2:52 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Treatment.com Ai Inc

< Previous 1 2 Next >
Repeat: Treatment.com AI Provides an Update on the Status of Exercised Warrants
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI Provides an Update on the Status of Exercised Warrants
From Treatment.com AI Inc.
Via GlobeNewswire
Repeat: Treatment.com AI Provides Latest Corporate Update
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI Provides Latest Corporate Update
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com International Inc’s (CSE: TRUE) Strategic Evolution in Health Tech
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treatment.com AI (CSE: TRUE) Revolutionizes Healthcare with AI: Strategic Partnerships and New Leadership Propel Innovation
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(OTCQX:WHTCF),(OTCQX:HWAIF),(NASDAQ:NVDA),(NYSE:VEEV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities
From FN Media Group LLC
Via GlobeNewswire
Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI Announces Contract Renewal with Leading US Medical School
From Treatment.com AI Inc.
Via GlobeNewswire
Repeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
From Treatment.com AI Inc.
Via GlobeNewswire
AI Transforms Healthcare Stocks in 2024: Revolutionizing Medicine Across the Globe
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:MDT),(NASDAQ:NVDA),(NASDAQ:LTRN),(OTCQX:HWAIF),(TSX:AIDX) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
From Treatment.com AI Inc.
Via GlobeNewswire
Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
From Treatment.com AI Inc.
Via GlobeNewswire
Emerging AI Healthcare Pioneers Promise Medical Breakthroughs and Investment Opportunities (CSE: TRUE)
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Revolutionizing Medical Histories: Treatment AI’s (CSE: TRUE) Pioneering Approach to Culturally Sensitive Data Collection
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treatment.com AI Inc. (CSE: TRUE) Secures NIH Funding to Pioneer Culturally Sensitive AI in Healthcare, Revolutionizes Medical Education with Groundbreaking AI Platform
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
From Treatment.com AI Inc.
Via GlobeNewswire
Revolutionizing Medical Diagnostics: Treatment.com AI’s Platform Passes Clinical Exam with Flying Colors, Signaling New Era for AI in Healthcare
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:PLTR),(NYSE:MDT),(NASDAQ:AMD),(NYSE:BFLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Disrupting Healthcare: How Treatment.com AI’s (TRUE.CN) Breakthrough Paves the Way for Tomorrow’s Medical Professionals
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
From FN Media Group LLC
Via GlobeNewswire
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
VANCOUVER, British Columbia, March 20, 2024 – Treatment.com AI Inc. (OTCQB: TREIF) (CSE: TRUE) (Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(OTCQX:HWAIF),(OTCQB:VRSSF),(NYSE:PATH),(NASDAQ:LTRN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
From Treatment.com AI Inc.
Via GlobeNewswire
TREATMENT.COM AI INC. CLOSES OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF $2,908,200
From Treatment.com AI Inc.
Via GlobeNewswire
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028
From FN Media Group LLC
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.